CLINICAL_TRIALS
trial_result
· 2018-01-17
Clinical Trial Update: Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray [Phase 2, Phase 3]
Summary
Phase 2/3 trial of intranasal scopolamine spray for motion sickness was terminated; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Repurposed Therapeutics, Inc. | Conditions: Motion Sickness | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2018-01-17